About Us
We’re a HealthTech company founded by world-renowned team of visionary doctors to transform the future of healthcare by providing personalized care based on individualized risk assessment.
Our initial focus is diabetic eye disease, one of leading causes of blindness which can be prevented in over 90% of cases with early detection.
The clinically validated RetinaRisk algorithm empowers patients and doctors alike by accurately calculating the risk of sight-threatening eye disease, while at the same time leading to efficiency and substantial savings in healthcare cost.
The Company
Risk Medical Solutions (RMS) was founded in 2009 by Professor Einar Stefánsson, MD – Retinal Specialist and former Chair of the Landspitali University Hospital Department of Ophthalmology, Dr. Arna Guðmundsdóttir, MD – Diabetologist at Landspitali University Hospital, Department of Endocrinology and Professor Thor Aspelund – Epidemiology and Biostatistics at the Center of Public Health Sciences, Faculty of Medicine, University of Iceland. Our founders have over 30 years of academic and clinical experience in treating diabetic retinopathy and diabetes management. The RMS team is a diverse mix of individuals specialized in medicine, mathematics, statistics, computer programming, health care economics, law and business.
Collaboration and Support
The company has received significant support from the academic and healthcare community in Iceland and has received grants from the Icelandic Technology Development Fund, the Icelandic Innovation Center, and commercial banks amongst others. Amongst shareholders are the University of Iceland and the Icelandic University Hospital, who both contribute significant resources towards our work.
Featured in Forbes
Dr. Arna Gudmundsdottir has spent decades treating people with diabetes and knows that effective treatment often involves encouraging patients to take matters of care into their own hands. She helped make this possible when she and her co-founders began working on a method to aid people living with diabetes in monitoring their eye health. They developed RetinaRisk—an app that helps people determine, through an algorithm, their individualized risk of developing sight-threatening diabetic retinopathy, one of the leading causes of blindness in the world today.
